CompletedNot applicableNCT00462917

REVEAL III: Risk Evaluation and Education for Alzheimer's Disease

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Brigham and Women's Hospital
Principal Investigator
Robert Green, MD, MPH
Brigham and Women's Hospital
Intervention
Pleiotropic info, in-person disclosure(behavioral)
Enrollment
290 target
Eligibility
18-85 years · All sexes
Timeline
20072009

Study locations (4)

Collaborators

National Human Genome Research Institute (NHGRI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00462917 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease

← Back to all trials